InsiderClue
Stocks · Health care · Pharmaceutical Preparations

SUPERNUS PHARMACEUTICALS, INC.

SUPN Clue Score33
United States Fiscal year ends December CIK 0001356576 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Padmanabh P. Bhatt
18 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
412
$50.48
$20.80K
Padmanabh P. Bhatt
18 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
6,838
$49.55
$338.82K
Padmanabh P. Bhatt
17 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
22,290
$50.73
$1.13M
Padmanabh P. Bhatt
17 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
27,710
$49.95
$1.38M
Padmanabh P. Bhatt
16 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
15,886
$50.49
$802.08K
Padmanabh P. Bhatt
16 Mar 2026
Sr. VP of IP, CSO
Sold after exercise
34,114
$50.18
$1.71M
Georges Gemayel
6 Mar 2026
Director
Sold after exercise
8,787
$53.00
$465.71K
Bethany Sensenig
19 Feb 2026
Director
Sold after exercise
3,258
$51.27
$167.04K
Bethany Sensenig
19 Feb 2026
Director
Sold after exercise
1,217
$50.31
$61.23K
Frank Mottola
19 Dec 2025
SVP, Chief Tech. Ops. Officer
Sold after exercise
15,000
$50.47
$757.05K
Frank Mottola
19 Dec 2025
SVP, Chief Tech. Ops. Officer
Sold after exercise
5,000
$50.22
$251.10K
Padmanabh P. Bhatt
18 Dec 2025
Sr. VP of IP, CSO
Sold after exercise
710
$44.44
$31.55K
Show all 23 transactions →

What was left out

Form 4 filings counted 66
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 12
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 2,909,472
History held since 7 May 2012